ONCY News and Press, Oncolytics Biotech Inc. From 04/05/21

Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors Webinar will take place Monday April 12, 2021 at 2:00 pm ET Canada...

Oncolytics Biotech® Announces Upcoming Presentations at the AACR Annual Meeting PR Newswire SAN DIEGO and CALGARY, AB , March 10, 2021 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will present ...

Oncolytics Biotech Inc. (ONCY) Q4 2020 Results Conference Call March 05, 2021 08:30 AM ET Company Participants Jon Patton - Director, IR and Communication Dr. Matt Coffey - President and CEO Andrew de Guttadauro - Global Head, Business Development Kirk Look - CFO Conference Call Participants ...

Oncolytics Biotech (ONCY) announces that it has entered into an at-the-market ((ATM)) equity offering sales agreement with Canaccord Genuity to raise gross proceeds of up to $80M.The company plans to use the funds to support ongoing business development activities and clinical trials. ...

Oncolytics Biotech (ONCY): Q4 GAAP EPS of -C$0.21 misses by C$0.12.Cash and cash equivalents of C$31.2M. Press Release For further details see: Oncolytics Biotech EPS misses by $0.09

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Operational Highlights Conference call and webcast to take place on Friday, March 5, 2021 at 8:30 am ET Canada NewsWire SAN DIEGO, Calif. and CALGARY,...

FN Media Group Presents USA News Group News Commentary Vancouver, BC – February 24, 2021 – USA News Group –  The way we think about treating brain cancers is being quietly revolutionized, buried beneath recent headline-grabbing announcements...

Palm Beach, FL –February 23, 2021 – In the breast cancer therapy market, the rise in the prevalence of cancer, has propelled the T-cell therapy market over the last few years and it is projected to continue to do so for several years to come. T-cell therapy includes using gene...

Oncolytics Biotech® Reports Preclinical Data Demonstrating the Synergistic Anti-cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors Canada NewsWire Mayo Clinic shows pelareorep vastly improved persistence and efficacy of CAR T cell thera...

Comstock Mining (LODE) +285% after buying stake in lithium-ion battery recycler.TDH Holdings (PETZ) +248%.Dogness (International) (DOGZ) +110%.Oncolytics Biotech (ONCY) +54%.ZW Data Action Technologies (CNET) +42%.China Xiangtai Food (PLIN) +41%.AirNet Technology (ANTE) +34%.Aqua Metals ...